Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS)

Scott Kollins, Laurence Greenhill, James Swanson, Sharon Wigal, Howard Abikoff, James McCracken, Mark A Riddle, James McGough, Benedetto Vitiello, Tim Wigal, Anne Skrobala, Kelly Posner, Jaswinder Ghuman, Mark Davies, Charles Cunningham, Audrey Bauzo

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: To describe the rationale and design of the Preschool ADHD Treatment Study (PATS). METHOD: PATS was a National Institutes of Mental Health-funded, multicenter, randomized, efficacy trial designed to evaluate the short-term (5 weeks) efficacy and long-term (40 weeks) safety of methylphenidate (MPH) in preschoolers with attention-deficit/hyperactivity disorder (ADHD). Three hundred three subjects ages 3 to 5.5 years old who met criteria for a primary DSM-IV diagnosis of ADHD entered the trial. Subjects participated in an 8-phase, 70-week trial that included screening, parent training, baseline, open-label safety lead-in, double-blind crossover titration, double-blind parallel efficacy, open-label maintenance, and double-blind discontinuation. Medication response was assessed during the crossover titration phase using a combination of parent and teacher ratings. Special ethical considerations throughout the trial warranted a number of design changes. RESULTS: This report describes the design of this trial, the rationale for reevaluation and modification of the design, and the methods used to conduct the trial. CONCLUSIONS: The PATS adds to a limited literature and improves our understanding of the safety and efficacy of MPH in the treatment of preschoolers with ADHD, but changes in the design and problems in implementation of this study impose some specific limitations that need to be addressed in future studies. Copyright 2006

Original languageEnglish (US)
Pages (from-to)1275-1283
Number of pages9
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume45
Issue number11
DOIs
StatePublished - Nov 2006

Fingerprint

Attention Deficit Disorder with Hyperactivity
Methylphenidate
Safety
National Institute of Mental Health (U.S.)
Diagnostic and Statistical Manual of Mental Disorders
Maintenance

Keywords

  • Attention-deficit/hyperactivity disorder
  • Clinical trials
  • Methylphenidate
  • Preschool

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Developmental and Educational Psychology

Cite this

Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS). / Kollins, Scott; Greenhill, Laurence; Swanson, James; Wigal, Sharon; Abikoff, Howard; McCracken, James; Riddle, Mark A; McGough, James; Vitiello, Benedetto; Wigal, Tim; Skrobala, Anne; Posner, Kelly; Ghuman, Jaswinder; Davies, Mark; Cunningham, Charles; Bauzo, Audrey.

In: Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 45, No. 11, 11.2006, p. 1275-1283.

Research output: Contribution to journalArticle

Kollins, S, Greenhill, L, Swanson, J, Wigal, S, Abikoff, H, McCracken, J, Riddle, MA, McGough, J, Vitiello, B, Wigal, T, Skrobala, A, Posner, K, Ghuman, J, Davies, M, Cunningham, C & Bauzo, A 2006, 'Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS)', Journal of the American Academy of Child and Adolescent Psychiatry, vol. 45, no. 11, pp. 1275-1283. https://doi.org/10.1097/01.chi.0000235074.86919.dc
Kollins, Scott ; Greenhill, Laurence ; Swanson, James ; Wigal, Sharon ; Abikoff, Howard ; McCracken, James ; Riddle, Mark A ; McGough, James ; Vitiello, Benedetto ; Wigal, Tim ; Skrobala, Anne ; Posner, Kelly ; Ghuman, Jaswinder ; Davies, Mark ; Cunningham, Charles ; Bauzo, Audrey. / Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS). In: Journal of the American Academy of Child and Adolescent Psychiatry. 2006 ; Vol. 45, No. 11. pp. 1275-1283.
@article{8e369a20c8c34ee2b34f383c3363e673,
title = "Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS)",
abstract = "OBJECTIVE: To describe the rationale and design of the Preschool ADHD Treatment Study (PATS). METHOD: PATS was a National Institutes of Mental Health-funded, multicenter, randomized, efficacy trial designed to evaluate the short-term (5 weeks) efficacy and long-term (40 weeks) safety of methylphenidate (MPH) in preschoolers with attention-deficit/hyperactivity disorder (ADHD). Three hundred three subjects ages 3 to 5.5 years old who met criteria for a primary DSM-IV diagnosis of ADHD entered the trial. Subjects participated in an 8-phase, 70-week trial that included screening, parent training, baseline, open-label safety lead-in, double-blind crossover titration, double-blind parallel efficacy, open-label maintenance, and double-blind discontinuation. Medication response was assessed during the crossover titration phase using a combination of parent and teacher ratings. Special ethical considerations throughout the trial warranted a number of design changes. RESULTS: This report describes the design of this trial, the rationale for reevaluation and modification of the design, and the methods used to conduct the trial. CONCLUSIONS: The PATS adds to a limited literature and improves our understanding of the safety and efficacy of MPH in the treatment of preschoolers with ADHD, but changes in the design and problems in implementation of this study impose some specific limitations that need to be addressed in future studies. Copyright 2006",
keywords = "Attention-deficit/hyperactivity disorder, Clinical trials, Methylphenidate, Preschool",
author = "Scott Kollins and Laurence Greenhill and James Swanson and Sharon Wigal and Howard Abikoff and James McCracken and Riddle, {Mark A} and James McGough and Benedetto Vitiello and Tim Wigal and Anne Skrobala and Kelly Posner and Jaswinder Ghuman and Mark Davies and Charles Cunningham and Audrey Bauzo",
year = "2006",
month = "11",
doi = "10.1097/01.chi.0000235074.86919.dc",
language = "English (US)",
volume = "45",
pages = "1275--1283",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Limited",
number = "11",

}

TY - JOUR

T1 - Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS)

AU - Kollins, Scott

AU - Greenhill, Laurence

AU - Swanson, James

AU - Wigal, Sharon

AU - Abikoff, Howard

AU - McCracken, James

AU - Riddle, Mark A

AU - McGough, James

AU - Vitiello, Benedetto

AU - Wigal, Tim

AU - Skrobala, Anne

AU - Posner, Kelly

AU - Ghuman, Jaswinder

AU - Davies, Mark

AU - Cunningham, Charles

AU - Bauzo, Audrey

PY - 2006/11

Y1 - 2006/11

N2 - OBJECTIVE: To describe the rationale and design of the Preschool ADHD Treatment Study (PATS). METHOD: PATS was a National Institutes of Mental Health-funded, multicenter, randomized, efficacy trial designed to evaluate the short-term (5 weeks) efficacy and long-term (40 weeks) safety of methylphenidate (MPH) in preschoolers with attention-deficit/hyperactivity disorder (ADHD). Three hundred three subjects ages 3 to 5.5 years old who met criteria for a primary DSM-IV diagnosis of ADHD entered the trial. Subjects participated in an 8-phase, 70-week trial that included screening, parent training, baseline, open-label safety lead-in, double-blind crossover titration, double-blind parallel efficacy, open-label maintenance, and double-blind discontinuation. Medication response was assessed during the crossover titration phase using a combination of parent and teacher ratings. Special ethical considerations throughout the trial warranted a number of design changes. RESULTS: This report describes the design of this trial, the rationale for reevaluation and modification of the design, and the methods used to conduct the trial. CONCLUSIONS: The PATS adds to a limited literature and improves our understanding of the safety and efficacy of MPH in the treatment of preschoolers with ADHD, but changes in the design and problems in implementation of this study impose some specific limitations that need to be addressed in future studies. Copyright 2006

AB - OBJECTIVE: To describe the rationale and design of the Preschool ADHD Treatment Study (PATS). METHOD: PATS was a National Institutes of Mental Health-funded, multicenter, randomized, efficacy trial designed to evaluate the short-term (5 weeks) efficacy and long-term (40 weeks) safety of methylphenidate (MPH) in preschoolers with attention-deficit/hyperactivity disorder (ADHD). Three hundred three subjects ages 3 to 5.5 years old who met criteria for a primary DSM-IV diagnosis of ADHD entered the trial. Subjects participated in an 8-phase, 70-week trial that included screening, parent training, baseline, open-label safety lead-in, double-blind crossover titration, double-blind parallel efficacy, open-label maintenance, and double-blind discontinuation. Medication response was assessed during the crossover titration phase using a combination of parent and teacher ratings. Special ethical considerations throughout the trial warranted a number of design changes. RESULTS: This report describes the design of this trial, the rationale for reevaluation and modification of the design, and the methods used to conduct the trial. CONCLUSIONS: The PATS adds to a limited literature and improves our understanding of the safety and efficacy of MPH in the treatment of preschoolers with ADHD, but changes in the design and problems in implementation of this study impose some specific limitations that need to be addressed in future studies. Copyright 2006

KW - Attention-deficit/hyperactivity disorder

KW - Clinical trials

KW - Methylphenidate

KW - Preschool

UR - http://www.scopus.com/inward/record.url?scp=33750512365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750512365&partnerID=8YFLogxK

U2 - 10.1097/01.chi.0000235074.86919.dc

DO - 10.1097/01.chi.0000235074.86919.dc

M3 - Article

VL - 45

SP - 1275

EP - 1283

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

SN - 0890-8567

IS - 11

ER -